Influence of genotype, viral load and fibrosis on the sustained virologic response rate to pegylated interferon alpha-2a plus ribavirin, with or without amantadine, in chronic hepatitis C patients non-responders to alpha interferferon plus ribavirin

被引：0
|
作者：
Cheinquer, H.
Pessoa, M.
Sette, H., Jr.
Parise, E.
Parana, R.
Tatsch, F.
机构：
[1] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[2] Hosp Emilio Ribas, Sao Paulo, Brazil
[3] Pro Figado, Gastroenterol & Hepatol, Sao Paulo, Brazil
[4] Univ Fed Sao Paulo, Sao Paulo, Brazil
[5] Univ Fed Bahia, Salvador, BA, Brazil
[6] Roche, Sao Paulo, Brazil
来源：
JOURNAL OF CLINICAL VIROLOGY | 2006年 / 36卷
关键词：
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
下载
收藏
页码：S147 / S147
页数：1
相关论文
共 50 条
  • [21] Peginterferon alpha-2b plus ribavirin with or without amantidine for the treatment of non-responders to standard interferon and ribavirin
    Hasan, F
    Al-Khaldi, J
    Asker, H
    Al-Ajmi, M
    Owayed, S
    Varghese, R
    Siddique, L
    Al-Nakib, B
    ANTIVIRAL THERAPY, 2004, 9 (04) : 499 - 503
  • [22] Ribavirin followed by alpha interferon retreatment in relapsers and in non-responders to alpha interferon for chronic hepatitis C
    Bellobuono, A
    Mondazzi, L
    Tempini, S
    Bellati, G
    Ideo, G
    HEPATOLOGY, 1996, 23 (01) : P99 - P99
  • [23] High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study
    Luiz Caetano da Silva
    Leda Bassit
    Suzane Kioko Ono-Nita
    João Renato Rebello Pinho
    Ana Nishiya
    Carmen Lucia Madruga
    Flair José Carrilho
    Journal of Gastroenterology, 2002, 37 : 732 - 736
  • [24] High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study
    Da Silva, LC
    Bassit, L
    Ono-Nita, SK
    Pinho, JRR
    Nishiya, A
    Madruga, CL
    Carrilho, FJ
    JOURNAL OF GASTROENTEROLOGY, 2002, 37 (09) : 732 - 736
  • [25] Pegylated Interferon Alpha-2a and Ribavirin in the Treatment of Children with Chronic Hepatitis C
    Pawlowska, Malgorzata
    Halota, Waldemar
    GASTROENTEROLOGY, 2009, 136 (05) : A839 - A839
  • [26] Interferon-α plus ribavirin for the treatment of chronic hepatitis C in non-responders to interferon-α
    Tromm, A
    Greving, I
    Hueppe, D
    GASTROENTEROLOGY, 1999, 116 (04) : A834 - A834
  • [27] Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2
    Seo, Kayo
    Kim, Soo Ki
    Kim, Soo Ryang
    Ohtani, Aya
    Kobayashi, Mana
    Kato, Airi
    Morimoto, Eri
    Saijo, Yuka
    Kim, Ke Ih
    Imoto, Susumu
    Kim, Chi Wan
    Yano, Yoshihiko
    Kudo, Masatoshi
    Hayashi, Yoshitake
    DIGESTIVE DISEASES, 2017, 35 (06) : 541 - 547
  • [28] COST-EFFECTIVENESS ANALYSIS OF PEG-INTERFERON ALPHA-2A PLUS RIBAVIRIN VERSUS CONVENTIONAL INTERFERON ALPHA-2A PLUS RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C IN CHINA
    Chen, W.
    Wei, L.
    VALUE IN HEALTH, 2011, 14 (07) : A280 - A280
  • [29] Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavirin in chronic hepatitis C genotype 4
    Jose Urquijo, Juan
    Diago, Moises
    Boadas, Jaume
    Planas, Ramon
    Sola, Ricard
    Angel del Olmo, Juan
    Crespo, Javier
    Carlos Erdozain, Jose
    Dolores Anton, Maria
    Arocena, Carlos
    Suarez, Dolores
    Gine, Josep
    Barrera, Josep M.
    Garcia-Samaniego, Javier
    Perez, Ricardo
    Dalmau, Blai
    Montoro, Miguel
    ANNALS OF HEPATOLOGY, 2013, 12 (01) : 30 - 35
  • [30] A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients
    Idrees, Muhammad
    Riazuddin, Sheikh
    BMC GASTROENTEROLOGY, 2009, 9
12345